Esher Angela, Coutinho Tiago
Departamento de Política de Medicamentos e Assistência Farmacêutica, Escola Nacional de Saúde Pública, Fiocruz. R. Leopoldo Bulhões 1480, Manguinhos. 21041-210 Rio de Janeiro RJ Brasil.
Cien Saude Colet. 2017 Aug;22(8):2571-2580. doi: 10.1590/1413-81232017228.08622017.
The rational use of medicines (URM) is considered one of the key elements recommended by the World Health Organization (WHO) for pharmaceutical policies. The excessive increase in the use of medicines in many countries has been identified as a major barrier to the achievement of URM and is part of a phenomenon called the 'pharmaceuticalization' of the society. This paper aims to present innitiatives to rationalize the use of methylphenidate and its limits in Brazil, considering the concept of pharmaceuticalization of the society. It is an exploratory study, based on a narrative review of the scientific literature. Controversies about the uses of methylphenidate make it a good example of this phenomenon and may help in the reflection and construction of new paths to the limits found by the concept of rational use of medicines.
合理用药被视为世界卫生组织（WHO）推荐的制药政策关键要素之一。许多国家药品使用的过度增长已被认定为实现合理用药的主要障碍，并且是社会“医药化”现象的一部分。本文旨在提出使巴西哌甲酯使用合理化的举措及其局限性，同时考虑社会医药化的概念。这是一项基于对科学文献的叙述性综述的探索性研究。关于哌甲酯使用的争议使其成为这一现象的一个典型例子，并且可能有助于反思和构建应对合理用药概念所发现局限性的新途径。
